214 related articles for article (PubMed ID: 33245944)
1. Significant correlation between gross tumor volume (GTV) D98% and local control in multifraction stereotactic radiotherapy (MF-SRT) for unresected brain metastases.
Dupic G; Brun L; Molnar I; Leyrat B; Chassin V; Moreau J; Dedieu V; Khalil T; Verrelle P; Lapeyre M; Biau J
Radiother Oncol; 2021 Jan; 154():260-268. PubMed ID: 33245944
[TBL] [Abstract][Full Text] [Related]
2. Local control and radionecrosis of brain metastases from non-small-cell lung cancer treated by hypofractionated stereotactic radiotherapy: Evaluation of predictive factors.
Leyrat B; Khalill T; Lemaire JJ; Casile M; Molnar I; Dedieu V; Chassin V; Dupic G; Bellière A; Durando X; Lapeyre M; Verrelle P; Biau J
Clin Transl Radiat Oncol; 2022 Sep; 36():1-8. PubMed ID: 35733828
[TBL] [Abstract][Full Text] [Related]
3. The dosimetric parameters impact on local recurrence in stereotactic radiotherapy for brain metastases.
Berthet C; Lucia F; Bourbonne V; Schick U; Lecouillard I; Le Deroff C; Barateau A; de Crevoisier R; Castelli J
Br J Radiol; 2024 Mar; 97(1156):820-827. PubMed ID: 38377402
[TBL] [Abstract][Full Text] [Related]
4. Feasibility of a simultaneously integrated boost concept for hypofractionated stereotactic radiotherapy of unresected brain metastases.
Kornhuber C; Ensminger S; Hübsch P; Janich M; Leucht CA; Vordermark D; Dietzel CT
Radiat Oncol; 2023 May; 18(1):88. PubMed ID: 37217934
[TBL] [Abstract][Full Text] [Related]
5. Proposal of an Alternative Near-Minimum Isodose Surface DV-0.01 cc Equally Minimizing Gross Tumor Volume Below the Relevant Dose as the Basis for Dose Prescription and Evaluation of Stereotactic Radiosurgery for Brain Metastases.
Ohtakara K; Suzuki K
Cureus; 2024 Apr; 16(4):e57580. PubMed ID: 38707120
[TBL] [Abstract][Full Text] [Related]
6. Single-fraction versus multifraction spinal stereotactic radiosurgery for spinal metastases from renal cell carcinoma: secondary analysis of Phase I/II trials.
Ghia AJ; Chang EL; Bishop AJ; Pan HY; Boehling NS; Amini B; Allen PK; Li J; Rhines LD; Tannir NM; Tatsui CE; Brown PD; Yang JN
J Neurosurg Spine; 2016 May; 24(5):829-36. PubMed ID: 26799117
[TBL] [Abstract][Full Text] [Related]
7. Interfractional target changes in brain metastases during 13-fraction stereotactic radiotherapy.
Uto M; Ogura K; Katagiri T; Takehana K; Mizowaki T
Radiat Oncol; 2021 Jul; 16(1):140. PubMed ID: 34321033
[TBL] [Abstract][Full Text] [Related]
8. Single-fraction radiosurgery versus fractionated stereotactic radiotherapy in patients with brain metastases: a comparative study.
Loo M; Pin Y; Thierry A; Clavier JB
Clin Exp Metastasis; 2020 Jun; 37(3):425-434. PubMed ID: 32185576
[TBL] [Abstract][Full Text] [Related]
9. An Extremely Inhomogeneous Gross Tumor Dose is Suitable for Volumetric Modulated Arc-Based Radiosurgery with a 5-mm Leaf-Width Multileaf Collimator for Single Brain Metastasis.
Ohtakara K; Suzuki K
Cureus; 2023 Feb; 15(2):e35467. PubMed ID: 36999102
[TBL] [Abstract][Full Text] [Related]
10. Toxicity and time lapse between immunotherapy and stereotactic radiotherapy of brain metastases.
Cabanie C; Biau J; Durando X; Mansard S; Molnar I; Chassin V; Verrelle P; Khalil T; Lapeyre M; Dupic G
Cancer Radiother; 2021 Jul; 25(5):432-440. PubMed ID: 33836954
[TBL] [Abstract][Full Text] [Related]
11. Dosimetric characterization of hypofractionated Gamma Knife radiosurgery of large or complex brain tumors versus linear accelerator-based treatments.
Dong P; Pérez-Andújar A; Pinnaduwage D; Braunstein S; Theodosopoulos P; McDermott M; Sneed P; Ma L
J Neurosurg; 2016 Dec; 125(Suppl 1):97-103. PubMed ID: 27903198
[TBL] [Abstract][Full Text] [Related]
12. Inhomogeneous tumor dose distribution provides better local control than homogeneous distribution in stereotactic radiotherapy for brain metastases.
Lucia F; Key S; Dissaux G; Goasduff G; Lucia AS; Ollivier L; Pradier O; Schick U
Radiother Oncol; 2019 Jan; 130():132-138. PubMed ID: 30017105
[TBL] [Abstract][Full Text] [Related]
13. On the pitfalls of PTV in lung SBRT using type-B dose engine: an analysis of PTV and worst case scenario concepts for treatment plan optimization.
Leung RWK; Chan MKH; Chiang CL; Wong M; Blanck O
Radiat Oncol; 2020 May; 15(1):130. PubMed ID: 32471457
[TBL] [Abstract][Full Text] [Related]
14. Outcomes for Spine Stereotactic Body Radiation Therapy and an Analysis of Predictors of Local Recurrence.
Bishop AJ; Tao R; Rebueno NC; Christensen EN; Allen PK; Wang XA; Amini B; Tannir NM; Tatsui CE; Rhines LD; Li J; Chang EL; Brown PD; Ghia AJ
Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):1016-1026. PubMed ID: 26025777
[TBL] [Abstract][Full Text] [Related]
15. Stereotactic body radiotherapy of adrenal metastases-A dose-finding study.
Buergy D; Würschmidt F; Gkika E; Hörner-Rieber J; Knippen S; Gerum S; Balermpas P; Henkenberens C; Voglhuber T; Kornhuber C; Barczyk S; Röper B; Rashid A; Blanck O; Wittig A; Herold HU; Brunner TB; Sweeney RA; Kahl KH; Ciernik IF; Ottinger A; Izaguirre V; Putz F; König L; Hoffmann M; Combs SE; Guckenberger M; Boda-Heggemann J
Int J Cancer; 2022 Aug; 151(3):412-421. PubMed ID: 35383919
[TBL] [Abstract][Full Text] [Related]
16. Variation in current prescription practice of stereotactic body radiotherapy for peripherally located early stage non-small cell lung cancer: Recommendations for prescribing and recording according to the ACROP guideline and ICRU report 91.
de Jong EEC; Guckenberger M; Andratschke N; Dieckmann K; Hoogeman MS; Milder M; Møller DS; Nyeng TB; Tanadini-Lang S; Lartigau E; Lacornerie T; Senan S; Verbakel W; Verellen D; De Kerf G; Hurkmans C
Radiother Oncol; 2020 Jan; 142():217-223. PubMed ID: 31767472
[TBL] [Abstract][Full Text] [Related]
17. Volumetric reduction of brain metastases after stereotactic radiotherapy: Prognostic factors and effect on local control.
Kanayama N; Ikawa T; Ohira S; Hirata T; Morimoto M; Ogawa K; Teshima T; Konishi K
Cancer Med; 2022 Dec; 11(24):4806-4815. PubMed ID: 35535485
[TBL] [Abstract][Full Text] [Related]
18. Harmonization of dose prescription for lung stereotactic radiotherapy.
Beldjoudi G; Bosson F; Bernard V; Puel LM; Martel-Lafay I; Ayadi M; Tanguy R
Phys Imaging Radiat Oncol; 2022 Oct; 24():65-70. PubMed ID: 36213173
[TBL] [Abstract][Full Text] [Related]
19. Clinical results of mean GTV dose optimized robotic guided SBRT for liver metastases.
Andratschke N; Parys A; Stadtfeld S; Wurster S; Huttenlocher S; Imhoff D; Yildirim M; Rades D; Rödel CM; Dunst J; Hildebrandt G; Blanck O
Radiat Oncol; 2016 May; 11():74. PubMed ID: 27236333
[TBL] [Abstract][Full Text] [Related]
20. Five-Year Sustained Complete Remission With Minimal Adverse Effects Following Radiosurgery for 2-cm Brain Metastasis With Deep Eloquent Location From Lung Adenocarcinoma Despite Low Marginal Dose and High 12 Gy Volume.
Ohtakara K; Nakao M; Muramatsu H; Suzuki K
Cureus; 2023 Mar; 15(3):e36680. PubMed ID: 37113354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
